ATI Inc. (ATI): analysis and signal as of September 7, 2026
In short
The signal is weak with a score of 0,0. Third quarter 2026 guidance exceeds consensus but the equity multiple remains high compared to peers.
- Current signal
- weak (vote 3/3)
- Deterministic score
- +0.0 → signal expected by the scale : weak (September 10, 2026)
- Layers
- fundamentals : positive, price : positive, risks : neutral
Triggered rules
| Rule | Weight |
|---|---|
| penalizes a PEG above 2, the anticipated growth is overpaid (overvalued fast grower) | -1.5 |
| favors robust fundamental health (high Piotroski F-Score) | +1.5 |
| penalizes direct holding of US securities in a CTO (US estate tax at death), favors a UCITS ETF domiciled in IE | -1.0 |
| moderately favors an asset with robust operating profitability (RMW factor), cross-check with accounting quality (possible manipulation) | +0.5 |
| moderately favors a positive 12-1 month momentum (tailwind), BUT guardrail: costly rotation, long-term reversal, momentum crashes, a conviction signal, not a rotation trigger | +0.5 |
Thesis
ATI Inc. Supplies superalloys for defense and jet engines. The sector benefits from US rearmament and electrification. The forward equity multiple of 43,2x and the EBITDA margin decline in the second quarter contradict a value thesis. The upside profile remains fragile in a complacent regime.
Bull case
Third quarter 2026 guidance forecasts adjusted earnings per share of 1,31 to 1,37 USD. This figure exceeds the consensus of 1,12 USD. The analyst target stands at 232 USD. Short interest declines by 6,5 % to reach 2,56 % of the float. The ERISA victory of 27/07/2026 removes a charge of 1,5 Md USD.
Bear case
The forward equity multiple of 43,2x exceeds that of peers Carpenter, Haynes and Howmet. Adjusted EBITDA for the second quarter stands at 284,4 M USD against 326,4 M USD in the first quarter. The after-hours price on 4/09 reaches 203,87 USD. This level sits below the close of 210,65 USD. The Cboe regime shows complacency with a put/call ratio of 0,76 and a z of -1,39. Beta stands at 1,65 against the ^GSPC index.
Scenarios
The bullish scenario relies on guidance above consensus. The bearish scenario stems from the high multiple and the EBITDA decline. The upside profile remains retail with an overnight gain of 50,5 % over six months against an intraday of -6,8 %.
Risks
The main risk lies in the EBITDA deceleration and the equity multiple above peers. The complacent regime with a beta of 1,65 exposes the stock to increased volatility. The decline in short interest and the removed ERISA charge support the thesis but do not offset the margin decline.
Market positioning (short sellers)
- Short interest / shares outstanding
- 2.56 %
- Days to cover
- 2.02
- Settlement date
- 2026-08-14
- Source
- FINRA (disseminated on 2026-08-26)
Upcoming catalysts
| Date | Description |
|---|---|
| Resultats T3 2026 attendus fin octobre 2026 |
Signal history (last 12 months)
| Date | Signal | New fact |
|---|---|---|
| weak (3/3) | Personal analysis, not a recommendation. | |
| weak (single draw, outside the three-draw protocol) | unchanged | |
| moderate (single draw, outside the three-draw protocol) | unchanged |
Frequently asked questions
Why is the signal weak despite guidance above consensus?
Third quarter 2026 guidance of 1,31 to 1,37 USD exceeds the consensus of 1,12 USD. However, the forward equity multiple of 43,2x remains above peers. The adjusted EBITDA decline to 284,4 M USD in the second quarter contradicts the value thesis. The retail upside profile remains fragile in a complacent regime.
What is the impact of the ERISA victory?
The ERISA victory of 27/07/2026 removes a charge of 1,5 Md USD. This element supports the bullish thesis. It adds to the decline in short interest of 6,5 % and the guidance above consensus. These factors strengthen the upside profile of the stock.
How does the upside profile of the stock stand?
The upside profile is retail. The overnight gain reaches 50,5 % over six months. The intraday gain stands at -6,8 %. This profile remains fragile in a complacent regime. The beta of 1,65 against the ^GSPC index accentuates volatility.
Sources
The official filings below are the issuer's own, matched to this stock by its identifier (LEI, CIK or ISIN). The figures quoted above come from an automated arbitration: they have not been re-checked one by one.
- — 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits (SEC · 8-K)
- — 10-Q (SEC · 10-Q)
- — 8.01 Other Events; 9.01 Financial Statements and Exhibits (SEC · 8-K)
- — 8.01 Other Events; 9.01 Financial Statements and Exhibits (SEC · 8-K)
Automated AI analysis: limitations and transparency
- This content is an automated analysis produced using artificial intelligence. Personal analysis for information purposes — no personalised investment advice. MMR content consists of general research. It does not take account of your financial circumstances, objectives or risk tolerance. Data, analyses and results, including those produced using artificial intelligence, may contain errors, be incomplete or become outdated. No return or outcome is guaranteed. All investments carry a risk of partial or total loss of capital. Past performance and simulations do not predict future results. Before making any decision, check information against original sources and, where necessary, consult an authorised professional. You remain responsible for your investment decisions. This notice does not exclude or limit any liability that cannot legally be excluded or limited.
- Tool and analysis: QDNA, Aurélien Ambert.
- Analysis (arbitration) completed on September 7, 2026; this page was completed on September 8, 2026 at 01:12 (UTC).
- Interests: no position in the stock analysed (ATI) is recorded in the data consulted on (UTC). This does not confirm the absence of holdings or other interests. The situation at the analysis publication date has not been reconstructed.
- This declaration covers only recorded positions in this stock; it is not an exhaustive verification of other interests or remuneration.
- Methodology: analysis chain, score formula and scale described on the public methodology page.
- Analysis horizon: 2035.
See also
- Neighbouring stock in the same sector: AngloGold Ashanti plc (AU)
- All analysed stocks
- Public methodology